Breaking Finance News

Exponent, Inc. (NASDAQ:EXPO) has been downgraded to Sell in a statement by BidaskClub earlier today.

BidaskClub has downgraded Exponent, Inc. (NASDAQ:EXPO) to Sell in a statement released on Tuesday June 20, 2017.

Boasting a price of $58.50, Exponent, Inc. (NASDAQ:EXPO) traded 1.14% higher on the day. With the last stock price close down 15.05% from the two hundred day average, compared with the S&P 500 Index which has increased 0.04% over the date range. Exponent, Inc. has recorded a 50-day average of $66.61 and a two hundred day average of $61.45. Volume of trade was up over the average, with 245,729 shares of EXPO changing hands over the typical 107,594

Performance Chart

Exponent, Inc. (NASDAQ:EXPO)

With a total market value of $0, Exponent, Inc. has price-earnings ratio of 36.63 with a one year low of $48.42 and a one year high of $70.95 .

Brief Synopsis About Exponent, Inc. (NASDAQ:EXPO)

Exponent, Inc. (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences and vehicle analysis services. Its Environmental and Health segment includes chemical regulation and food safety; ecological and biological sciences; environmental and earth sciences, and health sciences. Exponent serves clients in automotive, government, health, insurance, manufacturing and technology, among others.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.